What is the Gennex Laboratories Ltd share price today?

The share price of BSE:GENNEX-X on 01 Oct 2026 (as of 15:05:53 IST) is ₹9.74.

What is the BSE:GENNEX-X 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the BSE:GENNEX-X 52 week high low range shows a high of ₹17.25 and a low of ₹7.05.

What is the Gennex Laboratories Ltd market cap?

As on 01 Oct 2026, Gennex Laboratories Ltd market cap is ₹2417330000.

What is the shareholding pattern of Gennex Laboratories Ltd Stock?

The shareholding pattern of Gennex Laboratories Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 23.63% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 76.37% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Gennex Laboratories Ltd?

The Price-to-Earnings (PE) ratio of Gennex Laboratories Ltd is 15.1699, and the Price-to-Book (PB) ratio is 1.5145, as on 01 Oct 2026.

Gennex Laboratories Share Price

9.28+0.53 (+6.06%)

-39.97% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+6.06%

1 Week

+15.71%

1 Month

-6.26%

3 Month

+2.77%

6 Month

-7.20%

YTD

-35.10%

1 Year

-39.97%

5 Year

+30.52%

10 Year

Max

+143.57%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

8.80

7.99

7.70

7.05

High

9.49

10.20

13.25

16.30

About

Gennex Laboratories Ltd is engaged in the manufacture and export of bulk drugs and intermediates.The product range of the company includes Guaiphenesin Methocarbamol Fluconazole and Phenazopyridine.

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMA-ANSE

DIVISLAB-ANSE

TORNTPHARM-ANSE

LAURUSLABS-ANSE

ZYDUSLIFE-ANSE

DRREDDY-ANSE

CIPLA-ANSE

MANKIND-ANSE

AUROPHARMA-ANSE

LUPIN-ANSE

GENNEX-XNSE

LTP

1W Low

1W High

Market cap (₹)

1771.95-6.3 (-0.35%)

1720.80

1854.80

4,24,202Cr

10030+315 (3.24%)

9622.85

10035

2,64,141Cr

4635-0.15 (-0.00%)

4555

4668.55

1,74,402Cr

2320-72 (-3.01%)

2207.10

2442

1,26,811Cr

1239-5 (-0.40%)

1184.55

1264.20

1,23,685Cr

1370+19.8 (1.47%)

1337.30

1390.70

1,11,868Cr

1392.2+12.2 (0.88%)

1360.60

1392.20

1,11,650Cr

2477.1-11.65 (-0.47%)

2457.35

2527.80

1,02,196Cr

1699+21.2 (1.26%)

1650.10

1699

96,951Cr

2012+3 (0.15%)

1974.05

2032

91,301Cr

8.77+0.75 (9.35%)

7.70

9.12

199Cr

Gennex Laboratories Share Price

9.28+0.53 (+6.06%)

-39.97% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years24%

3 years38%

Last year25%

Compounded Profit Growth

10 years-

5 years39%

3 years50%

Last year16%

Stock Price CAGR

10 years-

5 years4%

3 years-8%

1 year-43%

Return on Equity

10 years8%

5 years10%

3 years11%

Last year10%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	24%	38%	25%
-	39%	50%	16%
-	4%	-8%	-43%
8%	10%	11%	10%

Peer Comparison

Symbol

SUNPHARMA-A

DIVISLAB-A

TORNTPHARM-A

LAURUSLABS-A

ZYDUSLIFE-A

DRREDDY-A

CIPLA-A

MANKIND-A

AUROPHARMA-A

LUPIN-A

GENNEX-X

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,771.95	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
10,030	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,635	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,320	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,239	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,370	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,392.2	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,477.1	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,699	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,012	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr
8.77	₹199 Cr	10.28	0.19	0.91	₹21 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Dec 2021	Sep 2021	Jun 2021	Dec 2020	Sep 2020	Jun 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018	Dec 2017	Sep 2017
₹40 Cr	₹61 Cr	₹43 Cr	₹39 Cr	₹34 Cr	₹40 Cr	₹40 Cr	₹33 Cr	₹28 Cr	₹34 Cr	₹21 Cr	₹18 Cr	₹16 Cr	₹19 Cr	₹15 Cr	₹20 Cr	₹14 Cr	₹17 Cr	₹14 Cr	₹10 Cr	₹16 Cr	₹15 Cr	₹13 Cr	₹15 Cr	₹14 Cr	₹16 Cr	₹20 Cr	₹15 Cr	₹11 Cr	₹9 Cr	₹12 Cr	₹10 Cr
₹2 Cr	₹1 Cr	₹0	₹0	₹2 Cr	₹4 Cr	₹0	₹0	₹2 Cr	₹2 Cr	₹0	₹0	₹3 L	₹2 Cr	₹0	₹0	₹57 L	₹0	₹0	₹3 L	₹0	₹0	₹15 L	₹0	₹0	₹34 L	₹25 L	₹0	₹0	₹14 L	₹0	₹3 L
₹42 Cr	₹62 Cr	₹43 Cr	₹39 Cr	₹36 Cr	₹44 Cr	₹40 Cr	₹33 Cr	₹31 Cr	₹36 Cr	₹21 Cr	₹18 Cr	₹17 Cr	₹21 Cr	₹15 Cr	₹20 Cr	₹15 Cr	₹17 Cr	₹14 Cr	₹10 Cr	₹16 Cr	₹15 Cr	₹13 Cr	₹15 Cr	₹14 Cr	₹16 Cr	₹21 Cr	₹15 Cr	₹11 Cr	₹10 Cr	₹12 Cr	₹11 Cr
₹36 Cr	₹56 Cr	₹35 Cr	₹32 Cr	₹30 Cr	₹39 Cr	₹33 Cr	₹26 Cr	₹25 Cr	₹29 Cr	₹17 Cr	₹13 Cr	₹12 Cr	₹18 Cr	₹13 Cr	₹18 Cr	₹13 Cr	₹16 Cr	₹13 Cr	₹9 Cr	₹14 Cr	₹14 Cr	₹13 Cr	₹14 Cr	₹13 Cr	₹15 Cr	₹19 Cr	₹14 Cr	₹10 Cr	₹9 Cr	₹11 Cr	₹10 Cr
₹6 Cr	₹7 Cr	₹9 Cr	₹8 Cr	₹7 Cr	₹6 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹6 Cr	₹5 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹89 L	₹81 L	₹1 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹89 L	₹88 L	₹94 L	₹81 L
₹90 L	₹1 Cr	₹1 Cr	₹1 Cr	₹98 L	₹1 Cr	₹84 L	₹1 Cr	₹73 L	₹73 L	₹83 L	₹78 L	₹73 L	₹63 L	₹18 L	₹36 L	₹26 L	₹14 L	₹24 L	₹15 L	₹14 L	₹23 L	₹16 L	₹17 L	₹18 L	₹23 L	₹20 L	₹26 L	₹17 L	₹17 L	₹15 L	₹20 L
₹5 Cr	₹5 Cr	₹7 Cr	₹6 Cr	₹6 Cr	₹4 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹51 L	₹34 L	₹75 L	₹1 Cr	₹1 Cr	₹82 L	₹48 L	₹47 L	₹51 L	₹40 L
₹5 Cr	₹4 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹3 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹75 L	₹79 L	₹1 Cr	₹95 L	₹1 Cr	₹87 L	₹37 L	₹20 L	₹56 L	₹80 L	₹45 L	₹82 L	₹48 L	₹47 L	₹31 L	₹40 L

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
—	—	—	—	—	—	—	—	—	—
₹24 Cr	₹23 Cr	₹23 Cr	₹18 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr
₹0	₹6 Cr	₹6 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹198 Cr	₹158 Cr	₹142 Cr	₹62 Cr	₹31 Cr	₹27 Cr	₹23 Cr	₹21 Cr	₹19 Cr	₹18 Cr
₹198 Cr	₹158 Cr	₹142 Cr	₹62 Cr	₹31 Cr	₹27 Cr	₹23 Cr	₹21 Cr	₹19 Cr	₹18 Cr
₹223 Cr	₹187 Cr	₹170 Cr	₹80 Cr	₹44 Cr	₹40 Cr	₹36 Cr	₹34 Cr	₹32 Cr	₹31 Cr
₹10 Cr	₹8 Cr	₹6 Cr	₹6 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹43 Cr	₹14 Cr	₹13 Cr	₹16 Cr	₹0	₹0	₹0	₹0	₹35 L	₹9 L
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹8 L	₹10 L
₹3 L	-₹18 L	-₹23 L	-₹14 L	₹32,429	₹15 L	₹40 L	₹56 L	₹61 L	₹95 L
₹0	₹3 Cr	₹0	₹0	₹0	₹2 L	₹2 L	₹5 L	₹0	₹0
₹43 Cr	₹17 Cr	₹13 Cr	₹16 Cr	₹32,429	₹17 L	₹41 L	₹62 L	₹1 Cr	₹1 Cr
—	—	—	—	—	—	—	—	—	—
₹20 Cr	₹13 Cr	₹15 Cr	₹7 Cr	₹8 Cr	₹6 Cr	₹8 Cr	₹8 Cr	₹12 Cr	₹9 Cr
₹6 Cr	₹13 Cr	₹14 Cr	₹17 Cr	₹4 Cr	₹3 Cr	₹5 Cr	₹3 Cr	₹3 Cr	₹3 Cr
₹36 Cr	₹10 Cr	₹6 Cr	₹1 Cr	₹10 Cr	₹7 Cr	₹5 Cr	₹5 Cr	₹2 Cr	₹4 Cr
₹10 Cr	₹8 Cr	₹6 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹45 L	₹50 L
₹72 Cr	₹45 Cr	₹40 Cr	₹30 Cr	₹24 Cr	₹19 Cr	₹21 Cr	₹17 Cr	₹18 Cr	₹17 Cr
₹349 Cr	₹256 Cr	₹230 Cr	₹132 Cr	₹68 Cr	₹59 Cr	₹57 Cr	₹52 Cr	₹50 Cr	₹49 Cr
₹98 L	₹98 L	₹98 L	₹74 L	₹74 L	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr
₹79 Cr	₹24 Cr	₹19 Cr	₹17 Cr	₹10 Cr	₹7 Cr	₹5 Cr	₹5 Cr	₹3 Cr	₹4 Cr
—	—	—	—	—	—	—	—	—	—
₹85 Cr	₹82 Cr	₹76 Cr	₹92 Cr	₹31 Cr	₹30 Cr	₹30 Cr	₹30 Cr	₹29 Cr	₹28 Cr
₹25 Cr	₹23 Cr	₹21 Cr	₹18 Cr	₹17 Cr	₹16 Cr	₹15 Cr	₹14 Cr	₹13 Cr	₹12 Cr
₹61 Cr	₹60 Cr	₹56 Cr	₹74 Cr	₹14 Cr	₹14 Cr	₹15 Cr	₹16 Cr	₹16 Cr	₹16 Cr
₹13 Cr	₹5 Cr	₹2 Cr	₹2 L	₹0	₹0	₹0	₹0	₹0	₹23 L
₹1 L	₹1 L	₹1 L	₹1 L	₹7 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹7 Cr
₹1 L	₹1 L	₹1 L	₹1 L	₹7 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹7 Cr
₹87 L	₹87 L	₹88 L	₹65 L	₹32 L	₹2 Cr	₹22 L	₹22 L	₹22 L	₹22 L
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹17,797	₹10,636
₹84 Cr	₹75 Cr	₹68 Cr	₹83 Cr	₹21 Cr	₹23 Cr	₹22 Cr	₹23 Cr	₹23 Cr	₹23 Cr
—	—	—	—	—	—	—	—	—	—
₹54 Cr	₹36 Cr	₹25 Cr	₹16 Cr	₹8 Cr	₹5 Cr	₹7 Cr	₹5 Cr	₹2 Cr	₹3 Cr
₹44 Cr	₹14 Cr	₹18 Cr	₹9 Cr	₹11 Cr	₹8 Cr	₹6 Cr	₹10 Cr	₹10 Cr	₹10 Cr
₹52 Cr	₹56 Cr	₹61 Cr	₹15 Cr	₹8 Cr	₹1 Cr	₹91 L	₹3 Cr	₹1 Cr	₹63 L
₹1 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹60 L	₹1 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹1 Cr
₹113 Cr	₹74 Cr	₹57 Cr	₹8 Cr	₹19 Cr	₹21 Cr	₹18 Cr	₹8 Cr	₹11 Cr	₹11 Cr
₹265 Cr	₹181 Cr	₹162 Cr	₹49 Cr	₹47 Cr	₹36 Cr	₹35 Cr	₹29 Cr	₹28 Cr	₹26 Cr
₹192 Cr	₹137 Cr	₹122 Cr	₹19 Cr	₹23 Cr	₹17 Cr	₹14 Cr	₹12 Cr	₹10 Cr	₹9 Cr
₹349 Cr	₹256 Cr	₹230 Cr	₹132 Cr	₹68 Cr	₹59 Cr	₹57 Cr	₹52 Cr	₹50 Cr	₹49 Cr
₹9	₹8	₹7	₹5	₹3	₹3	₹3	₹3	₹3	₹2
₹9	₹8	₹7	₹5	₹3	₹3	₹3	₹3	₹2	₹2

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
₹23 Cr	₹21 Cr	₹16 Cr	₹6 Cr	₹5 Cr	₹5 Cr	₹3 Cr	₹3 Cr	₹1 Cr	₹3 Cr
-₹29 L	-₹4 Cr	₹2 Cr	-₹39 L	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr
-₹84 Cr	-₹25 Cr	-₹65 Cr	₹18 Cr	₹5 Cr	-₹7 Cr	-₹6 Cr	-₹3 Cr	₹1 Cr	-₹4 Cr
-₹61 Cr	-₹8 Cr	-₹47 Cr	₹24 Cr	₹13 Cr	₹10 L	-₹2 Cr	₹2 Cr	₹4 Cr	₹59 L
-₹64 Cr	-₹11 Cr	-₹47 Cr	₹24 Cr	₹12 Cr	-₹1 Cr	-₹2 Cr	₹2 Cr	₹3 Cr	-₹11 L
-₹5 Cr	₹82 L	₹19 Cr	-₹38 Cr	-₹2 Cr	-₹2 L	-₹22 L	-₹99 L	-₹67 L	-₹97 L
₹65 Cr	₹5 Cr	₹74 Cr	₹21 Cr	-₹2 Cr	₹2 Cr	-₹35 L	₹1 Cr	-₹2 Cr	₹86 L
-₹3 Cr	-₹5 Cr	₹46 Cr	₹6 Cr	₹8 Cr	₹16 L	-₹2 Cr	₹2 Cr	₹39 L	-₹22 L
₹56 Cr	₹61 Cr	₹15 Cr	₹9 Cr	₹1 Cr	₹91 L	₹3 Cr	₹1 Cr	₹63 L	₹85 L
₹52 Cr	₹56 Cr	₹61 Cr	₹15 Cr	₹9 Cr	₹1 Cr	₹91 L	₹3 Cr	₹1 Cr	₹63 L

Fundamental Ratios

Consolidated

Standalone

No results found

Gennex Laboratories Share Price

9.28+0.53 (+6.06%)

-39.97% past 1 Year

Shareholding summary

Promoters

23.63%

FII

DII

Others

76.37%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
23.63%	23.63%	23.63%	23.62%	23.62%	19.83%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
76.37%	76.37%	76.37%	76.38%	76.38%	80.17%

Bulk & block deals

Name

Anupriya Consultants Pvt Ltd

Kamal Kumar Dugar And Co ( Prop : Kamal Kumar Dugar)

Dorite Tracon Private Limited

Narantak Dealcomm Limited

Tropical Agro System India Private Limited

Maryada Barter Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
22 May 2026	Purchase	1.52 Cr	₹11.92	12.75 L	Bulk	0.524804	BSE
22 May 2026	Sell	76.88 L	₹12.30	6.25 L	Bulk	0.257257	BSE
19 May 2026	Purchase	1.93 Cr	₹9.97	19.35 L	Bulk	0.796378	BSE
15 Oct 2025	Sell	1.62 Cr	₹13.81	11.75 L	Bulk	0.483643	BSE
15 Oct 2025	Purchase	2.06 Cr	₹13.75	15.02 L	Bulk	0.618124	BSE
14 Oct 2025	Purchase	2.67 Cr	₹13.37	20 L	Bulk	0.823222	BSE
30 Sep 2025	Sell	1.87 Cr	₹11.01	17 L	Bulk	0.699739	BSE
12 Mar 2025	Purchase	1.54 Cr	₹12.73	12.07 L	Bulk	0.497007	BSE

Insider trading & SAST

Client name

Premier Fiscal Services Pvt Ltd

Premier Fiscal Services Private Limited

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
16 Jul 2025	Promoter	Acquisition	4.21	15.81	0	—	1 Cr	04 Jun 2025 - 04 Jul 2025	Pref. Allotment	3,75,38,000	SAST	29(2)	—
10 Jul 2025	Promoter	Acquisition	2.263862	21.83	8.11 Cr	₹14.75	55 L	08 Jul 2025	Allotment	5,30,38,000	Insider Trading	—	Equity Shares
07 Jul 2025	Promoter	Acquisition	2.592378	20.02	8.85 Cr	₹14.75	60 L	04 Jul 2025	Allotment	4,75,38,000	Insider Trading	—	Equity Shares
07 Jul 2025	Promoter	Acquisition	2.526872	20.02	8.85 Cr	₹14.75	60 L	04 Jul 2025	Allotment	4,75,38,000	Insider Trading	—	Equity Shares
05 Jun 2025	Promoter	Acquisition	1.758646	17.95	5.90 Cr	₹14.75	40 L	04 Jun 2025	Allotment	4,15,38,000	Insider Trading	—	Equity Shares
05 Jun 2025	Promoter	Acquisition	1.728252	17.95	5.90 Cr	₹14.75	40 L	04 Jun 2025	Allotment	4,15,38,000	Insider Trading	—	Equity Shares

Gennex Laboratories Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Gennex Laboratories Share Price

Gennex Laboratories Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Gennex Laboratories Share Price

Gennex Laboratories Share Price

Oscillators

Moving averages

Gennex Laboratories Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Gennex Laboratories Share Price

Corporate Actions

Company details

Gennex Laboratories Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Gennex Laboratories Share Price

News

Gennex Lab reports Profit after tax of 3.00 Crores, in the March 2026 quarter

Gennex Lab reports Profit after tax of 4.45 Crores, in the December 2025 quarter

Gennex Lab reports Profit after tax of 4.53 Crores, in the September 2025 quarter

Gennex Lab - Quaterly Results

Gennex Lab - Quaterly Results

Gennex Lab reports Profit after tax of 4.15 Crores, in the June 2025 quarter

Gennex Laboratories informs about outcome of board meeting

Gennex Lab reports Profit after tax of 1.50 Crores, in the March 2025 quarter

Gennex Laboratories informs about disclosures

Gennex Laboratories informs about disclosure

Gennex Laboratories informs about disclosure

Gennex Lab reports Profit after tax of 4.21 Crores, in the December 2024 quarter

Gennex Lab reports Profit after tax of 4.16 Crores, in the September 2024 quarter

Gennex Laboratories informs about compliance certificate

Gennex Lab - Quaterly Results

Gennex Lab reports Profit after tax of 4.17 Crores, in the June 2024 quarter

Gennex Lab reports Profit after tax of 3.93 Crores, in the March 2024 quarter

Gennex Lab - Quaterly Results

Gennex Laboratories informs about newspaper publication

Gennex Lab - Quaterly Results

Gennex Laboratories Ltd Share Price Today

Gennex Laboratories Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator